Supernus Pharmaceuticals
SUPN
#3722
Rank
$1.95 B
Marketcap
$36.25
Share price
1.83%
Change (1 day)
18.43%
Change (1 year)

Earnings for Supernus Pharmaceuticals (SUPN)

Earnings in 2022 (TTM): $39.06 M

According to Supernus Pharmaceuticals 's latest financial reports the company's current earnings (TTM) are $39.06 M. In 2021 the company made an earning of $96.59 M a decrease over its 2020 earnings that were of $0.19 B.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Supernus Pharmaceuticals from 2013 to 2022

Annual earnings

Year Earnings Change
2022 (TTM)$39.06 M-59.56%
2021$96.59 M-49.79%
2020$0.19 B13.05%
2019$0.17 B7.52%
2018$0.15 B54.9%
2017$0.10 B92.31%
2016$53.13 M228%
2015$16.2 M-34.77%
2014$24.83 M-129.42%
2013-$84.43 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
$22.51 B 57,546.43%๐Ÿ‡บ๐Ÿ‡ธ USA
$9.31 B 23,740.36%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.54 B 16,667.10%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.71 B 19,641.96%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.22 B-642.78%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.93 B 2,298.88%๐Ÿ‡บ๐Ÿ‡ธ USA